[Wiskott-Aldrich syndrome. A report of a new mutation].

dc.contributor.authorGuillén-Rocha, Nelva
dc.contributor.authorLópez-Rocha, Eunice
dc.contributor.authorDanielian, Silvia
dc.contributor.authorSegura-Méndez, Nora
dc.contributor.authorLópez-González, Lucina
dc.contributor.authorLugo-Reyes, Saúl Oswaldo
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-24T15:06:47Z
dc.date.available2026-03-24T15:06:47Z
dc.date.issued2014
dc.descriptionVol. 61, No. 3, pp. 219-23
dc.description.abstractWiskott-Aldrich syndrome was first reported clinically in 1937, and in 1954 the classic triad was identified: eccema, recurrent infections and thrombocytopenia with an X-linked transmission. Its incidence is estimated at 1 to 10 in one million live births per year. Wiskott Aldrich syndrome is caused by mutations in a gene in the short arm of chromosome X that encodes the Wiskott-Aldrich syndrome protein (WASp), which identification and sequencing was first performed in 1994, and since then about 300 mutations have been reported. This paper describes the case of a boy with Wiskott-Aldrich syndrome, with clinical and genetic diagnosis, with a considerable diagnostic delay attributable to an atypical presentation misdiagnosed as immune thrombocytopenia.spa
dc.description.sponsorshipAlergia e Inmunología Clínica, Cochabamba, Bolivia. dr.lugo.reyes@gmail.com.
dc.identifier.issn0002-5151
dc.identifier.otherPMID:25177856
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/25177856/
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/101272
dc.language.isospa
dc.relation.ispartofRevista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
dc.sourcePubMed
dc.subjectPersistent thrombocytopenia
dc.subjectPrimary immunodeficiency
dc.subjectWiskott-Aldrich syndrome
dc.title[Wiskott-Aldrich syndrome. A report of a new mutation].
dc.typeArtículo Científico Publicado

Files